An Open-Label, Multi-Centre, Non-Interventional, Post-Marketing Surveillance (PMS) to Monitor the Safety and Effectiveness of Votrient Administered in Korean Patients According to the Prescribing Information (115578) First published 16/12/2013 Last updated 31/03/2024 EU PAS number:EUPAS5153 Study Finalised